Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on June 23, 2005
J Am Soc Nephrol 16: 2403-2411, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2004121101

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2004121101v1
16/8/2403    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, M. J.
Right arrow Articles by Bruggeman, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, M. J.
Right arrow Articles by Bruggeman, L. A.

Pathophysiology of Renal Disease and Progression

NF-{kappa}B Regulates Fas-Mediated Apoptosis in HIV-Associated Nephropathy

Michael J. Ross*, Scott Martinka{dagger}, Vivette D. D’Agati{ddagger} and Leslie A. Bruggeman{dagger}

* Division of Nephrology, Mount Sinai Medical Center, New York, New York; {dagger} Rammelkamp Center for Education and Research and Department of Medicine, MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio; and {ddagger} Department of Pathology, Columbia University College of Physicians and Surgeons, New York, New York

Address correspondence to: Dr. Leslie Bruggeman, Department of Medicine, Case Western Reserve University, Rammelkamp Building R429, MetroHealth Medical Center, 2500 MetroHealth Drive, Cleveland, OH 44109. Phone: 216-778-7603; Fax: 216-778-4321; E-mail: leslie.bruggeman{at}case.edu

Received for publication December 20, 2004. Accepted for publication May 23, 2005.

Renal parenchymal injury in HIV-associated nephropathy (HIVAN) is characterized by epithelial proliferation, dedifferentiation, and apoptosis along the entire length of the nephron. Although apoptotic cell death in HIVAN has been well documented, the mechanism for HIV-induced apoptosis is poorly understood. Whether the epithelial apoptosis in HIVAN is mediated by NF-{kappa}B–activated Fas ligand expression was investigated here. In human HIVAN and HIV-1 transgenic mouse kidney specimens, the expression of Fas receptor and ligand proteins were markedly upregulated on epithelium in diseased glomerular and tubulointerstitial compartments when compared with normal. Podocyte cell lines that were derived from HIV-1 transgenic mice showed a similar upregulation of Fas receptor expression and de novo expression of Fas ligand by semiquantitative reverse transcription–PCR and Western blotting. In cultured podocytes, cross-linking of the Fas receptor to mimic ligand binding induced caspase 8 activity and apoptosis in both normal and HIVAN podocytes. Because constitutive NF-{kappa}B activity has been demonstrated in HIVAN epithelia, evidence for transcriptional control of the Fas ligand expression by NF-{kappa}B was sought. With the use of cultured podocytes, expression of a Fas ligand promoter reporter plasmid was higher in HIVAN podocytes, indicating increased transcriptional activity. In addition, chromatin immunoprecipitation assays were performed to demonstrate that p65-containing (RelA) complexes bound the Fas ligand promoter and that suppression of activated NF-{kappa}B with a peptide inhibitor could reduce the expression of Fas ligand mRNA in HIVAN podocytes. These results suggest that NF-{kappa}B may regulate Fas-mediated apoptosis in HIVAN by controlling the expression of Fas ligand in renal epithelium.




This article has been cited by other articles:


Home page
CJASNHome page
L. A. Bruggeman
Viral Subversion Mechanisms in Chronic Kidney Disease Pathogenesis
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(Supplement_1): S13 - S19.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
K. Kiryluk, J. Martino, and A. G. Gharavi
Genetic Susceptibility, HIV Infection, and the Kidney
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(Supplement_1): S25 - S35.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Tandon, I. Levental, C. Huang, F. J. Byfield, J. Ziembicki, J. R. Schelling, L. A. Bruggeman, J. R. Sedor, P. A. Janmey, and R. T. Miller
HIV infection changes glomerular podocyte cytoskeletal composition and results in distinct cellular mechanical properties
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F701 - F710.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Szabo, A. Biser, R. Benko, E. Bottinger, and K. Susztak
Poly(ADP-Ribose) Polymerase Inhibitors Ameliorate Nephropathy of Type 2 Diabetic Leprdb/db Mice
Diabetes, November 1, 2006; 55(11): 3004 - 3012.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Albaqumi, T. J. Soos, L. Barisoni, and P. J. Nelson
Collapsing Glomerulopathy
J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2854 - 2863.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Martinka and L. A. Bruggeman
Persistent NF-{kappa}B activation in renal epithelial cells in a mouse model of HIV-associated nephropathy
Am J Physiol Renal Physiol, March 1, 2006; 290(3): F657 - F665.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP